{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:02:50Z","timestamp":1788876170365,"version":"build-2803163510"},"reference-count":88,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013968","name":"Johnson and Johnson Vision Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ophthalmologyscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Science"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.xops.2025.100949","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:49:29Z","timestamp":1758955769000},"page":"100949","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Measuring Treatment Adherence in Myopia Control"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5647-9346","authenticated-orcid":false,"given":"Rebecca M.","family":"Dang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Jalbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xops.2025.100949_bib1","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/OPX.0000000000002119","article-title":"Myopia control: seeing beyond efficacy","volume":"101","author":"Bullimore","year":"2024","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.xops.2025.100949_bib2","series-title":"Adherence to Long-Term Therapies: Evidence for Action","author":"Sabat\u00e9","year":"2003"},{"key":"10.1016\/j.xops.2025.100949_bib3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.xops.2025.100949_bib4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.mlr.0000204287.82701.9b","article-title":"Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes","volume":"44","author":"Cantrell","year":"2006","journal-title":"Med Care"},{"key":"10.1016\/j.xops.2025.100949_bib5","first-page":"35","article-title":"Adherence and health care costs","volume":"7","author":"Iuga","year":"2014","journal-title":"Risk Manag Healthc Policy"},{"key":"10.1016\/j.xops.2025.100949_bib6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/01.mlr.0000163641.86870.af","article-title":"Impact of medication adherence on hospitalization risk and healthcare cost","volume":"43","author":"Sokol","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.xops.2025.100949_bib7","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1037\/hea0000778","article-title":"Positive affect and medication adherence in chronic conditions: a systematic review","volume":"38","author":"Bassett","year":"2019","journal-title":"Health Psychol"},{"key":"10.1016\/j.xops.2025.100949_bib8","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1001\/jamaophthalmol.2016.3793","article-title":"Association between adherence to glasses wearing during amblyopia treatment and improvement in visual acuity","volume":"134","author":"Maconachie","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2025.100949_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ophtha.2019.10.022","article-title":"The association between medication adherence and visual field progression in the collaborative initial glaucoma treatment study","volume":"127","author":"Newman-Casey","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100949_bib10","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/archdischild-2014-306243","article-title":"Adherence in childhood asthma: the elephant in the room","volume":"99","author":"Morton","year":"2014","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.xops.2025.100949_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.eplepsyres.2018.03.018","article-title":"The prevalence rates of medication adherence and factors influencing adherence to antiepileptic drugs in children with epilepsy: a systematic review and meta analysis","volume":"142","author":"Yang","year":"2018","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.xops.2025.100949_bib12","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1167\/iovs.04-0971","article-title":"A randomized controlled trial of unilateral strabismic and mixed amblyopia using occlusion dose monitors to record compliance","volume":"46","author":"Awan","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100949_bib13","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1167\/iovs.13-11861","article-title":"Compliance with occlusion therapy for childhood amblyopia","volume":"54","author":"Wallace","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100949_bib14","first-page":"1258","article-title":"Adherence to medical treatment in childhood glaucoma","volume":"59","author":"Edward","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100949_bib15","article-title":"Investing in medication adherence improves health outcomes and health system efficiency: adherence to medicines for diabetes, hypertension, and hyperlipidaemia","volume":"105","author":"Khan","year":"2018","journal-title":"OECD Health Working Papers No"},{"key":"10.1016\/j.xops.2025.100949_bib16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/iovs.64.6.6","article-title":"IMI-global trends in myopia management attitudes and strategies in clinical practice-2022 update","volume":"64","author":"Wolffsohn","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100949_bib17","article-title":"Interventions for myopia control in children: a living systematic review and network meta-analysis","volume":"2","author":"Lawrenson","year":"2025","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.xops.2025.100949_bib18","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/S0149-2918(99)80026-5","article-title":"Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice","volume":"21","author":"Farmer","year":"1999","journal-title":"Clin Ther"},{"key":"10.1016\/j.xops.2025.100949_bib19","first-page":"1","article-title":"Medication adherence measures: an overview","volume":"2015","author":"Lam","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.xops.2025.100949_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.7326\/M18-0543","article-title":"ESPACOMP Medication Adherence Reporting Guideline (EMERGE)","volume":"169","author":"De Geest","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.xops.2025.100949_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.15386\/mpr-1201","article-title":"An overview of the common methods used to measure treatment adherence","volume":"92","author":"Anghel","year":"2019","journal-title":"Med Pharm Rep"},{"key":"10.1016\/j.xops.2025.100949_bib22","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11096-013-9865-x","article-title":"Assessing medication adherence: options to consider","volume":"36","author":"Lehmann","year":"2014","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.xops.2025.100949_bib23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/eye.2013.277","article-title":"Visual regulation of refractive development: insights from animal studies","volume":"28","author":"Smith","year":"2014","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.xops.2025.100949_bib24","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/OPX.0000000000001410","article-title":"A 3-year randomized clinical trial of MiSight lenses for myopia control","volume":"96","author":"Chamberlain","year":"2019","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.xops.2025.100949_bib25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/opo.12621","article-title":"Myopia control with novel central and peripheral plus contact lenses and extended depth of focus contact lenses: 2 year results from a randomised clinical trial","volume":"39","author":"Sankaridurg","year":"2019","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.xops.2025.100949_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/bjophthalmol-2013-303914","article-title":"Defocus Incorporated Soft Contact (DISC) lens slows myopia progression in Hong Kong Chinese schoolchildren: a 2-year randomised clinical trial","volume":"98","author":"Lam","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100949_bib27","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jamaophthalmol.2022.0401","article-title":"Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial","volume":"140","author":"Bao","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2025.100949_bib28","article-title":"Randomized trial of soft contact lenses with novel ring focus for controlling myopia progression","volume":"3","author":"Cheng","year":"2023","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.xops.2025.100949_bib29","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jama.2020.10834","article-title":"Effect of high add power, medium add power, or single-vision contact lenses on myopia progression in children: the BLINK randomized clinical trial","volume":"324","author":"Walline","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.xops.2025.100949_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.clae.2020.11.015","article-title":"Exploring non-adherence to contact lens wear schedule: subjective assessments and patient related factors in children wearing single vision and myopia control contact lenses","volume":"44","author":"Weng","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.xops.2025.100949_bib31","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/OPX.0000000000001106","article-title":"A randomized trial of soft multifocal contact lenses for myopia control: baseline data and methods","volume":"94","author":"Walline","year":"2017","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.xops.2025.100949_bib32","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s00417-018-3906-z","article-title":"MiSight Assessment Study Spain (MASS). A 2-year randomized clinical trial","volume":"256","author":"Ruiz-Pomeda","year":"2018","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2025.100949_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.optom.2020.11.003","article-title":"Predicting factors for progression of the myopia in the MiSight assessment study Spain (MASS)","volume":"15","author":"Prieto-Garrido","year":"2022","journal-title":"J Optom"},{"key":"10.1016\/j.xops.2025.100949_bib34","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1167\/iovs.07-0804","article-title":"Role of near work in myopia: findings in a sample of Australian school children","volume":"49","author":"Ip","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.xops.2025.100949_bib35","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1007\/s11606-020-05905-z","article-title":"Using electronic monitoring devices to assess medication adherence: a research methods framework","volume":"35","author":"McGrady","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.xops.2025.100949_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3389\/fphar.2017.00100","article-title":"Current situation of medication adherence in hypertension","volume":"8","author":"Vrijens","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.xops.2025.100949_bib37","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ajo.2024.08.020","article-title":"Spectacle lenses with highly aspherical lenslets for slowing axial elongation and refractive change in low-hyperopic Chinese children: a randomized controlled trial","volume":"269","author":"Zhang","year":"2025","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100949_bib38","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s13142-015-0315-2","article-title":"Self-report measures of medication adherence behavior: recommendations on optimal use","volume":"5","author":"Stirratt","year":"2015","journal-title":"Transl Behav Med"},{"key":"10.1016\/j.xops.2025.100949_bib39","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mlr.0000129496.05898.02","article-title":"The concordance of self-report with other measures of medication adherence: a summary of the literature","volume":"42","author":"Garber","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/j.xops.2025.100949_bib40","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s10461-012-0172-7","article-title":"A proposal for quality standards for measuring medication adherence in research","volume":"17","author":"Williams","year":"2013","journal-title":"AIDS Behav"},{"key":"10.1016\/j.xops.2025.100949_bib41","article-title":"Trajectories of myopia control and orthokeratology compliance among parents with myopic children","volume":"44","author":"Chang","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.xops.2025.100949_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph181910316","article-title":"A cooperative management app for parents with myopic children wearing orthokeratology lenses: mixed methods pilot study","volume":"18","author":"Sun","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.xops.2025.100949_bib43","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12916-020-01773-w","article-title":"Use of wearable biometric monitoring devices to measure outcomes in randomized clinical trials: a methodological systematic review","volume":"18","author":"Gra\u00f1a Possamai","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/j.xops.2025.100949_bib44","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1021\/acsnano.8b00829","article-title":"Wearable contact lens biosensors for continuous glucose monitoring using smartphones","volume":"12","author":"Elsherif","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.xops.2025.100949_bib45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.clae.2021.02.007","article-title":"CLEAR - contact lens technologies of the future","volume":"44","author":"Jones","year":"2021","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.xops.2025.100949_bib46","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1023\/A:1014131928789","article-title":"Electronic monitoring of medication adherence: when is high-tech best?","volume":"9","author":"Riekert","year":"2002","journal-title":"J Clin Psychol Med Settings"},{"key":"10.1016\/j.xops.2025.100949_bib47","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.9612","article-title":"Effect of repeated low-level red light on myopia prevention among children in china with premyopia: a randomized clinical trial","volume":"6","author":"He","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.xops.2025.100949_bib48","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s40123-023-00875-x","article-title":"The effects of repeated low-level red-light therapy on the structure and vasculature of the choroid and retina in children with premyopia","volume":"13","author":"Liu","year":"2024","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.xops.2025.100949_bib49","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.ophtha.2024.05.023","article-title":"Repeated low-level red light therapy for myopia control in high myopia children and adolescents: a randomized clinical trial","volume":"131","author":"Xu","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100949_bib50","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ophtha.2021.11.023","article-title":"Effect of repeated low-level red-light therapy for myopia control in children: a multicenter randomized controlled trial","volume":"129","author":"Jiang","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100949_bib51","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/bjophthalmol-2019-314819","article-title":"Low-dose (0.01%) atropine eye-drops to reduce progression of myopia in children: a multicentre placebo-controlled randomised trial in the UK (CHAMP-UK)-study protocol","volume":"104","author":"Azuara-Blanco","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100949_bib52","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1111\/aos.15761","article-title":"Myopia outcome study of atropine in children: two-year result of daily 0.01% atropine in a European population","volume":"102","author":"Loughman","year":"2024","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.xops.2025.100949_bib53","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1001\/jamaophthalmol.2023.2855","article-title":"Low-dose 0.01% atropine eye drops vs placebo for myopia control: a randomized clinical trial","volume":"141","author":"Repka","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2025.100949_bib54","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jamaophthalmol.2023.2097","article-title":"Efficacy and safety of 0.01% and 0.02% atropine for the treatment of pediatric myopia progression over 3 years: a randomized clinical trial","volume":"141","author":"Zadnik","year":"2023","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2025.100949_bib55","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100949_bib56","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1136\/jnnp.2005.064709","article-title":"Measuring therapy adherence in Parkinson\u2019s disease: a comparison of methods","volume":"77","author":"Grosset","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.xops.2025.100949_bib57","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ajh.2009.207","article-title":"Assessing medication adherence simultaneously by electronic monitoring and pill count in patients with mild-to-moderate hypertension","volume":"23","author":"van Onzenoort","year":"2010","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.xops.2025.100949_bib58","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1023\/A:1011396711486","article-title":"Comparing objective measures of adherence to HIV antiretroviral therapy: electronic medication monitors and unannounced pill counts","volume":"5","author":"Bangsberg","year":"2001","journal-title":"AIDS Behav"},{"key":"10.1016\/j.xops.2025.100949_bib59","article-title":"Use of pharmacy records to measure treatment adherence: a critical review of the literature","volume":"33","author":"Lima-Dellamora","year":"2017","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.xops.2025.100949_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2020.104092","article-title":"Pitfalls of medication adherence approximation through EHR and pharmacy records: definitions, data and computation","volume":"136","author":"Galozy","year":"2020","journal-title":"Int J Med Inform"},{"key":"10.1016\/j.xops.2025.100949_bib61","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1378\/chest.12-1055","article-title":"Daily diaries vs retrospective questionnaires to assess asthma control and therapeutic responses in asthma clinical trials: is participant burden worth the effort?","volume":"143","author":"Okupa","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.xops.2025.100949_bib62","series-title":"Handbook of Individual Differences in Social Behavior","first-page":"624","author":"Leary","year":"2009"},{"key":"10.1016\/j.xops.2025.100949_bib63","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1086\/323201","article-title":"Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: comparison of self-report and electronic monitoring","volume":"33","author":"Arnsten","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.xops.2025.100949_bib64","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1136\/bmj.324.7347.1193","article-title":"Patient non-compliance with paper diaries","volume":"324","author":"Stone","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.xops.2025.100949_bib65","first-page":"1110","article-title":"Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study","volume":"106","author":"Lam","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100949_bib66","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1136\/bjo-2021-321005","article-title":"Control of myopia using diffusion optics spectacle lenses: 12-month results of a randomised controlled, efficacy and safety study (CYPRESS)","volume":"107","author":"Rappon","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100949_bib67","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/OPX.0000000000001378","article-title":"Bifocal & atropine in myopia study: baseline data and methods","volume":"96","author":"Huang","year":"2019","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.xops.2025.100949_bib68","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s10384-021-00822-y","article-title":"Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study","volume":"65","author":"Hieda","year":"2021","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.xops.2025.100949_bib69","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","article-title":"Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children: a randomized clinical trial","volume":"138","author":"Wei","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2025.100949_bib70","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","article-title":"Low-concentration atropine for myopia progression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control","volume":"126","author":"Yam","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100949_bib71","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2)","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100949_bib72","first-page":"63","article-title":"Multiple surveys of students and survey fatigue","volume":"2004","author":"Porter","year":"2004","journal-title":"New Dir Inst Res"},{"key":"10.1016\/j.xops.2025.100949_bib73","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00417-022-05794-4","article-title":"Low-intensity red-light therapy in slowing myopic progression and the rebound effect after its cessation in Chinese children: a randomized controlled trial","volume":"261","author":"Chen","year":"2023","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.xops.2025.100949_bib74","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ophtha.2022.08.024","article-title":"Myopia control effect of repeated low-level red-light therapy in Chinese children: a randomized, double-blind, controlled clinical trial","volume":"130","author":"Dong","year":"2023","journal-title":"Ophthalmology"},{"key":"10.1016\/j.xops.2025.100949_bib75","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s40123-022-00644-2","article-title":"Clinically significant axial shortening in myopic children after repeated low-level red light therapy: a retrospective multicenter analysis","volume":"12","author":"Wang","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.xops.2025.100949_bib76","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.japh.2022.09.007","article-title":"A systematic review of primary care-focused, self-reported medication adherence tools","volume":"63","author":"Rickles","year":"2023","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.xops.2025.100949_bib77","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.japh.2023.07.002","article-title":"Concerns regarding factual errors in Rickles et al. March 2023 review of self-reported medication adherence tools","volume":"63","author":"Svarstad","year":"2023","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.xops.2025.100949_bib81","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.jfo.2021.07.005","article-title":"Myopia progression and axial elongation in Spanish children: efficacy of atropine 0.01% eye-drops","volume":"44","author":"Moriche-Carretero","year":"2021","journal-title":"J Fr Ophtalmol"},{"issue":"Suppl 2","key":"10.1016\/j.xops.2025.100949_bib78","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1097\/ICL.0000000000000413","article-title":"MiSight assessment study spain: a comparison of vision-related quality-of-life measures between MiSight contact lenses and single-vision spectacles","volume":"44","author":"Pomeda","year":"2018","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.xops.2025.100949_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2023.101849","article-title":"Six years of wearer experience in children participating in a myopia control study of MiSight\u00ae 1 day","volume":"46","author":"Lumb","year":"2023","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/j.xops.2025.100949_bib80","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jamaophthalmol.2024.5703","article-title":"Efficacy and safety of different atropine regimens for the treatment of myopia in children: three-year results of the MOSAIC randomized clinical trial","volume":"143","author":"Loughman","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.xops.2025.100949_bib82","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.pra.0000367776.96012.ca","article-title":"Assessment of adherence problems in patients with serious and persistent mental illness: recommendations from the expert consensus guidelines","volume":"16","author":"Velligan","year":"2010","journal-title":"J Psychiatr Pract"},{"key":"10.1016\/j.xops.2025.100949_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.690680","article-title":"Survey fatigue during the COVID-19 pandemic: an analysis of neurosurgery survey response rates","volume":"8","author":"de Koning","year":"2021","journal-title":"Front Surg"},{"key":"10.1016\/j.xops.2025.100949_bib84","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Med Care"},{"key":"10.1016\/j.xops.2025.100949_bib85","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1524-4733.2008.00400.x","article-title":"Development and evaluation of the Adherence to Refills and Medications Scale (ARMS) among low-literacy patients with chronic disease","volume":"12","author":"Kripalani","year":"2009","journal-title":"Value Health"},{"key":"10.1016\/j.xops.2025.100949_bib86","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2165\/11537400-000000000-00000","article-title":"Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices","volume":"28","author":"Shi","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.xops.2025.100949_bib87","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/00007632-200208150-00020","article-title":"Computerized questionnaires and the quality of survey data","volume":"27","author":"Hanscom","year":"2002","journal-title":"Spine"},{"key":"10.1016\/j.xops.2025.100949_bib88","first-page":"1087","article-title":"Context of atropine adherence in preschool children with early-onset myopia: a qualitative study","volume":"11","author":"Ho","year":"2024","journal-title":"Children (Basel)"}],"container-title":["Ophthalmology Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525002477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666914525002477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T21:10:50Z","timestamp":1772053850000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666914525002477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":88,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666914525002477"],"URL":"https:\/\/doi.org\/10.1016\/j.xops.2025.100949","relation":{},"ISSN":["2666-9145"],"issn-type":[{"value":"2666-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measuring Treatment Adherence in Myopia Control","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xops.2025.100949","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 by the American Academy of Ophthalmology.","name":"copyright","label":"Copyright"}],"article-number":"100949"}}